303 Views | 260 Downloads
Valérie Biousse, MD, Departments of Ophthalmology and Neurology, Emory University School of Medicine, 1365-B Clifton Rd NE, Atlanta, GA 30322; vbiouss@emory.edu
Dr Biousse had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Kahraman-Koytak, Newman, Biousse; Acquisition, analysis, or interpretation of data: All authors; Drafting of the manuscript: Kahraman-Koytak, Newman, Biousse; Critical revision of the manuscript for important intellectual content: All authors; Statistical analysis: Bruce; Obtained funding: Newman, Biousse; Administrative, technical, or material support: Newman, Biousse; Supervision: Bruce, Peragallo, Newman, Biousse.
Dr Bruce served as a consultant for MedImmune (data safety and monitoring board) and Bayer (medicolegal).
Dr Newman is a consultant for Gensight Biologics (France), serves on the data safety monitoring board for Quark Pharmaceuticals (Israel) clinical trial, has provided expert testimony on the topic of optic disc edema, and has received research support from the National Institutes of Health (NIH) (grants R01-NS089694, P30-EY006360) and the Research to Prevent Blindness Lew R. Wasserman Merit Award.
Dr Biousse is a consultant for Gensight Biologics (France), received research support from the NIH/Public Health Service (grant P30-EY006360), the NIH (grant R01-NS089694), and Research to Prevent Blindness.
This study was supported in part by an unrestricted departmental grant (Department of Ophthalmology) from Research to Prevent Blindness; and by NIH/National Eye Institute core grant P30-EY006360 (Department of Ophthalmology).
© 2018 American Medical Association. All rights reserved.